Variant report
Variant | esv3368612 |
---|---|
Chromosome Location | chr5:1661552-1664550 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199634065 | chr5:1661564-1661565 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386684447 | chr5:1661581-1661582 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112301396 | chr5:1661582-1661583 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs904736 | chr5:1661583-1661584 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs571040505 | chr5:1661623-1661624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529920600 | chr5:1661712-1661713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370710077 | chr5:1661725-1661726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1875193 | chr5:1661736-1661737 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs193030808 | chr5:1661764-1661765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537181283 | chr5:1661765-1661766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72719246 | chr5:1661770-1661771 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs71670013 | chr5:1661797-1661798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371795297 | chr5:1661806-1661807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11948318 | chr5:1661812-1661813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs561118703 | chr5:1661813-1661814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184783830 | chr5:1661866-1661867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372853348 | chr5:1661932-1661933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376506906 | chr5:1661995-1661996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79586082 | chr5:1662034-1662035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557572446 | chr5:1662044-1662045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575727540 | chr5:1662074-1662075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546300078 | chr5:1662102-1662103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190037272 | chr5:1662122-1662123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368559639 | chr5:1662133-1662134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181247767 | chr5:1662155-1662156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562062942 | chr5:1662156-1662157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11952443 | chr5:1662184-1662185 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs548174814 | chr5:1662217-1662218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185420135 | chr5:1662218-1662219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11954684 | chr5:1662235-1662236 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs530588200 | chr5:1662239-1662240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs386684448 | chr5:1662251-1662252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11951713 | chr5:1662253-1662254 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs188170079 | chr5:1662258-1662259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143686563 | chr5:1662261-1662262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567709066 | chr5:1662284-1662285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs57015017 | chr5:1662295-1662296 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs138331596 | chr5:1662331-1662332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181969096 | chr5:1662389-1662390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186301937 | chr5:1662395-1662396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575810647 | chr5:1662397-1662398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142922448 | chr5:1662398-1662399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558235501 | chr5:1662412-1662413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116436536 | chr5:1662418-1662419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115739194 | chr5:1662419-1662420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145122019 | chr5:1662428-1662429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72719248 | chr5:1662429-1662430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542125709 | chr5:1662443-1662444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs57743634 | chr5:1662455-1662456 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs138979858 | chr5:1662463-1662464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1658400-1662800 | Weak transcription | Right Atrium | heart |
2 | chr5:1660600-1663000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:1661400-1661600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
4 | chr5:1662800-1663000 | Flanking Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr5:1662800-1663400 | ZNF genes & repeats | Gastric | stomach |
6 | chr5:1662800-1663400 | ZNF genes & repeats | Right Atrium | heart |
7 | chr5:1663000-1663200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr5:1663000-1663200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:1663200-1663400 | Bivalent/Poised TSS | Hela-S3 | cervix |
10 | chr5:1663200-1665200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr5:1663400-1666600 | Weak transcription | Right Atrium | heart |
12 | chr5:1663400-1667000 | Weak transcription | Gastric | stomach |